Atlas Trials

Intravesicular Abraxane for Treatment-Refractory Bladder Cancer

Clinical trial NCT00583349 · COMPLETED

Trial details

NCT number
NCT00583349
Sponsor
Columbia University
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Bladder Cancer
Start date
2008-12-01
Primary completion
2013-03-01
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.